REQUEST A DEMO
Total
USD $0.00
Search more companies

Gencell Pharma S A S (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Gencell Pharma S A S Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Gencell Pharma S A S is based in Colombia. The head office is in Bogota D.C.. The company operates in the Diagnostic Imaging Centers sector. It was incorporated on January 14, 2011. 256 (2024) employees currently work for Gencell Pharma S A S. From the latest financial highlights, Gencell Pharma S A S reported a net sales revenue drop of 9.53% in 2023. Its total assets decreased by 18.71% over the same period. The net profit margin of Gencell Pharma S A S decreased by 11.89% in 2023.

Headquarters
Carrera 18 No 82-15
Bogota D.C.; Bogota D.C; Postal Code: 0813

Contact Details: Purchase the Gencell Pharma S A S report to view the information.

Basic Information
Total Employees:
Purchase the Gencell Pharma S A S report to view the information.
Outstanding Shares:
Purchase the Gencell Pharma S A S report to view the information.
Incorporation Date:
January 14, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Gencell Pharma S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-9.53%
Total operating revenue
-9.53%
Operating profit (EBIT)
-43.18%
EBITDA
-34.81%
Net Profit (Loss) for the Period
-72.28%
Total assets
-18.71%
Total equity
5.37%
Operating Profit Margin (ROS)
-8.34%
Net Profit Margin
-11.89%
Return on Equity (ROE)
-14.27%
Debt to Equity Ratio
-31.51%
Quick Ratio
2.22%
Cash Ratio
0.42%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?